Huimeng Qi
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 14, 2023
Retraction Note: SNHG6 modulates oxidized low-density lipoprotein-induced endothelial cells injury through miR-135a-5p/ROCK in atherosclerosis.
Journal: Cell & bioscience
Published: July 25, 2023
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice.
Journal: Cellular & molecular biology letters
Published: June 14, 2023
Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: October 14, 2022
A long non-coding RNA H19/microRNA-138/TLR3 network is involved in high phosphorus-mediated vascular calcification and chronic kidney disease.
Journal: Cell cycle (Georgetown, Tex.)
Published: April 18, 2022
CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
Journal: Biochemical and biophysical research communications
Published: July 11, 2020
MicroRNA-16 directly binds to DEC2 and inactivates the TLR4 signaling pathway to inhibit lupus nephritis-induced kidney tissue hyperplasia and mesangial cell proliferation.
Journal: International immunopharmacology
Published: May 19, 2020
MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1.
Journal: Experimental cell research
Published: May 10, 2020
miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.
Journal: Biochemical and biophysical research communications
Published: November 04, 2019
NORAD affects the progression of diabetic nephropathy through targeting miR-520h to upregulate TLR4.
NORAD affects the progression of diabetic nephropathy through targeting miR-520h to upregulate TLR4.
Journal: Biochemical and biophysical research communications
Published: September 11, 2019
MicroRNA-96 regulates pancreatic β cell function under the pathological condition of diabetes mellitus through targeting Foxo1 and Sox6.
Journal: Biochemical and biophysical research communications
Published: August 27, 2019
SNHG6 modulates oxidized low-density lipoprotein-induced endothelial cells injury through miR-135a-5p/ROCK in atherosclerosis.
Journal: Cell & bioscience
Published: June 24, 2019
Last Updated: 09/26/2026